STELLANTIS NV (STLAP.PA) Stock Fundamental Analysis

EPA:STLAP • NL00150001Q9

6.442 EUR
-0.34 (-5.04%)
Last: Mar 2, 2026, 07:00 PM
Fundamental Rating

2

Overall STLAP gets a fundamental rating of 2 out of 10. We evaluated STLAP against 31 industry peers in the Automobiles industry. STLAP may be in some trouble as it scores bad on both profitability and health. STLAP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year STLAP has reported negative net income.
  • In the past year STLAP has reported a negative cash flow from operations.
  • Each year in the past 5 years STLAP has been profitable.
  • Each year in the past 5 years STLAP had a positive operating cash flow.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

  • STLAP has a worse Return On Assets (-1.19%) than 61.29% of its industry peers.
  • STLAP has a Return On Equity (-3.27%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • In the last couple of years the Profit Margin of STLAP has declined.
  • STLAP's Operating Margin has declined in the last couple of years.
  • The Gross Margin of STLAP (7.74%) is worse than 70.97% of its industry peers.
  • In the last couple of years the Gross Margin of STLAP has remained more or less at the same level.
  • STLAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

  • STLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STLAP has been reduced compared to 1 year ago.
  • STLAP has more shares outstanding than it did 5 years ago.
  • STLAP has a worse debt/assets ratio than last year.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • STLAP has an Altman-Z score of 1.32. This is a bad value and indicates that STLAP is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.32, STLAP is doing good in the industry, outperforming 61.29% of the companies in the same industry.
  • A Debt/Equity ratio of 0.38 indicates that STLAP is not too dependend on debt financing.
  • STLAP has a Debt to Equity ratio of 0.38. This is in the better half of the industry: STLAP outperforms 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC6.82%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

  • STLAP has a Current Ratio of 1.06. This is a normal value and indicates that STLAP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of STLAP (1.06) is worse than 67.74% of its industry peers.
  • STLAP has a Quick Ratio of 1.06. This is a bad value and indicates that STLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.77, STLAP is doing worse than 70.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

  • STLAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.87%.
  • STLAP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.26% yearly.
  • The Revenue for STLAP has decreased by -17.07% in the past year. This is quite bad
  • STLAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.72% yearly.
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

  • STLAP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.95% yearly.
  • STLAP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.12% yearly.
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y5.95%
Revenue Next Year-2.19%
Revenue Next 2Y1.33%
Revenue Next 3Y2.16%
Revenue Next 5Y3.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

  • STLAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 4.38, which indicates a rather cheap valuation of STLAP.
  • 87.10% of the companies in the same industry are more expensive than STLAP, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. STLAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.38
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STLAP indicates a somewhat cheap valuation: STLAP is cheaper than 67.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.84
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%

0

5. Dividend

5.1 Amount

  • STLAP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

STELLANTIS NV

EPA:STLAP (3/2/2026, 7:00:00 PM)

6.442

-0.34 (-5.04%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners45.78%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap18.71B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts71.11
Price Target8.45 (31.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.34
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.59%
PT rev (3m)-10.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-38.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.38
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.8
EV/EBITDA 5.84
EPS(TTM)-0.83
EYN/A
EPS(NY)1.47
Fwd EY22.82%
FCF(TTM)-4.67
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.32
BVpS25.18
TBVpS8.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.66%
ROCE(5y)12.71%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 6.13
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.32
F-Score1
WACC6.82%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y5.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.19%
Revenue Next 2Y1.33%
Revenue Next 3Y2.16%
Revenue Next 5Y3.12%
EBIT growth 1Y-115.72%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year-7.53%
EBIT Next 3Y23.04%
EBIT Next 5Y21.38%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / STLAP.PA FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to STLAP.PA.


What is the valuation status of STELLANTIS NV (STLAP.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (STLAP.PA). This can be considered as Overvalued.


What is the profitability of STLAP stock?

STELLANTIS NV (STLAP.PA) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for STLAP stock?

The Earnings per Share (EPS) of STELLANTIS NV (STLAP.PA) is expected to decline by -95.93% in the next year.


How sustainable is the dividend of STELLANTIS NV (STLAP.PA) stock?

The dividend rating of STELLANTIS NV (STLAP.PA) is 0 / 10 and the dividend payout ratio is -81.93%.